Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 288-917-4 | CAS number: 85940-28-9
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
The toxicokinetics of phosphorodithioic acid, mixed O,O-bis(2-ethylhexyl and iso-Bu and iso-Pr) esters, zinc salts has not been directly studied. Oral studies indicate that these salts may be absorbed to a limited extent in the gastrointestinal track resulting in further distribution and metabolism. Because of its high lipophilicity, it may distribute in fatty tissues and be released slowly; however, none of the repeat-dose oral studies report significant effects other than reddened adrenal and pituitary glands and organ weight changes at very high doses, without histopathological evidence to indicate systemic toxicity. The liver is expected to be the primary organ to receive and metabolize the substance, making it more soluble by oxidation and conjugation for eventual release into the bile and into the gastrointestinal tract for elimination. EC 288-917-4 is above the size threshold expected to easily penetrate skin, however with prolonged and concentrated application accompanied by skin irritation, it may produce minimal systemic effects. The degree of absorption of EC 288-917-4 through the skin or gastrointestinal system is likely limited, but regardless of the route of exposure, there is no indication that systemically distributed phosphorodithioic acid, mixed O,O-bis(2-ethylhexyl and iso-Bu and iso-Pr) esters, zinc salts will bioaccumulate.
Discussion on bioaccumulation potential result:
This substance is expected to have a log kow of 8.87 and a high molecular weight of 705.288; both outside the optimal window for intestinal/dermal absorption.The lack of adverse findings following oral dosing (LD50> 3080 mg/kg for acute toxicity; NOAEL 125 mg/kg/d for repeat dose toxicity), or dermal dosing (LD50 > 20,000 mg/kg) may be at least partially due to limited gastrointestinal/dermal absorption of the test substance after treatment, and/or a very low index of inherent toxicity for this substance, and/or its metabolite(s).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
